Frequencies of CD70 expression in biopsies from patients with systemic or cutaneous T-cell lymphomas
| Lymphoma subtype . | n . | CD70 expression (%) . | |||
|---|---|---|---|---|---|
| <5, n (%) . | 5-25, n (%) . | 25-50, n (%) . | >50, n (%) . | ||
| Cutaneous T-cell lymphoma | 20 | ||||
| Mycosis fungoides | 13 | 1 (8) | 5 (38) | 1 (8) | 6 (46) |
| pcALCL | 7 | 0 (0) | 2 (29) | 4 (57) | 1 (14) |
| Systemic T-cell lymphoma | 29 | ||||
| PTCL | 14 | 5 (36) | 2 (14) | 3 (21) | 4 (29) |
| ALCL, ALK+ | 9 | 2 (22) | 1 (11) | 0 (0) | 6 (67) |
| ALCL, ALK− | 6 | 3 (50) | 0 (0) | 0 (0) | 3 (50) |
| Lymphoma subtype . | n . | CD70 expression (%) . | |||
|---|---|---|---|---|---|
| <5, n (%) . | 5-25, n (%) . | 25-50, n (%) . | >50, n (%) . | ||
| Cutaneous T-cell lymphoma | 20 | ||||
| Mycosis fungoides | 13 | 1 (8) | 5 (38) | 1 (8) | 6 (46) |
| pcALCL | 7 | 0 (0) | 2 (29) | 4 (57) | 1 (14) |
| Systemic T-cell lymphoma | 29 | ||||
| PTCL | 14 | 5 (36) | 2 (14) | 3 (21) | 4 (29) |
| ALCL, ALK+ | 9 | 2 (22) | 1 (11) | 0 (0) | 6 (67) |
| ALCL, ALK− | 6 | 3 (50) | 0 (0) | 0 (0) | 3 (50) |